Post-marketing Study Assessing the Serious Cardiovascular Events Among Osteoporotic Patients Initiating Romosozumab in Japan Using the Medical Information Database Network (MID-NET) (20190206)First published 23/09/2024 Last updated 08/01/2025 EU PAS number: EUPAS1000000308StudyOngoing